Literature DB >> 21502492

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure.

Amy W Chung1, Gamze Isitman, Marjon Navis, Marit Kramski, Rob J Center, Stephen J Kent, Ivan Stratov.   

Abstract

Effective immunity to HIV is poorly understood. In particular, a role for antibody-dependent cellular cytotoxicity (ADCC) in controlling HIV is controversial. We hypothesized that significant pressure from HIV-specific ADCC would result in immune-escape variants. A series of ADCC epitopes in HIV-infected subjects to specific consensus strain HIV peptides were mapped using a flow cytometric assay for natural killer cell activation. We then compared the ADCC responses to the same peptide epitope derived from the concurrent HIV sequence(s) expressed in circulating virus. In 9 of 13 epitopes studied, ADCC antibodies were unable to recognize the concurrent HIV sequence. Our studies suggest ADCC responses apply significant immune pressure on the virus. This result has implications for the induction of ADCC responses by HIV vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21502492      PMCID: PMC3088575          DOI: 10.1073/pnas.1016048108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand.

Authors:  Chitraporn Karnasuta; Robert M Paris; Josephine H Cox; Sorachai Nitayaphan; Punnee Pitisuttithum; Prasert Thongcharoen; Arthur E Brown; Sanjay Gurunathan; James Tartaglia; William L Heyward; John G McNeil; Deborah L Birx; Mark S de Souza
Journal:  Vaccine       Date:  2005-03-31       Impact factor: 3.641

2.  Rapid viral escape at an immunodominant simian-human immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost.

Authors:  Caroline S Fernandez; Ivan Stratov; Robert De Rose; Katrina Walsh; C Jane Dale; Miranda Z Smith; Michael B Agy; Shiu-Lok Hu; Kendall Krebs; David I Watkins; David H O'connor; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition.

Authors:  R E Phillips; S Rowland-Jones; D F Nixon; F M Gotch; J P Edwards; A O Ogunlesi; J G Elvin; J A Rothbard; C R Bangham; C R Rizza
Journal:  Nature       Date:  1991-12-12       Impact factor: 49.962

4.  Vaccine-induced T cells control reversion of AIDS virus immune escape mutants.

Authors:  Caroline S Fernandez; Miranda Z Smith; C Jane Batten; Robert De Rose; Jeanette C Reece; Erik Rollman; Vanessa Venturi; Miles P Davenport; Stephen J Kent
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

5.  A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity.

Authors:  V Raúl Gómez-Román; Ruth H Florese; L Jean Patterson; Bo Peng; David Venzon; Kris Aldrich; Marjorie Robert-Guroff
Journal:  J Immunol Methods       Date:  2005-11-28       Impact factor: 2.303

6.  Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.

Authors:  Warren L Dinges; Julia Richardt; David Friedrich; Emilie Jalbert; Yi Liu; Claire E Stevens; Janine Maenza; Ann C Collier; Daniel E Geraghty; Jeremy Smith; Zoe Moodie; James I Mullins; M Juliana McElrath; Helen Horton
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

7.  Induction of T-cell immunity to antiretroviral drug-resistant human immunodeficiency virus type 1.

Authors:  Ivan Stratov; C Jane Dale; Socheata Chea; James McCluskey; Stephen J Kent
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

8.  Vaccine-elicited antibodies mediate antibody-dependent cellular cytotoxicity correlated with significantly reduced acute viremia in rhesus macaques challenged with SIVmac251.

Authors:  V Raúl Gómez-Román; L Jean Patterson; David Venzon; David Liewehr; Kris Aldrich; Ruth Florese; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

9.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

10.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection.

Authors:  Douglas D Richman; Terri Wrin; Susan J Little; Christos J Petropoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

View more
  89 in total

Review 1.  Beyond Viral Neutralization.

Authors:  George K Lewis; Marzena Pazgier; David T Evans; Guido Ferrari; Stylianos Bournazos; Matthew S Parsons; Nicole F Bernard; Andrés Finzi
Journal:  AIDS Res Hum Retroviruses       Date:  2017-02-16       Impact factor: 2.205

Review 2.  The high cost of fidelity.

Authors:  Sarah B Lloyd; Stephen J Kent; Wendy R Winnall
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01       Impact factor: 2.205

3.  HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV.

Authors:  Vijaya Madhavi; Bruce D Wines; Janaki Amin; Sean Emery; Ester Lopez; Anthony Kelleher; Rob J Center; P Mark Hogarth; Amy W Chung; Stephen J Kent; Ivan Stratov
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

4.  Anti-HIV-1 ADCC Antibodies following Latency Reversal and Treatment Interruption.

Authors:  Wen Shi Lee; Anne B Kristensen; Thomas A Rasmussen; Martin Tolstrup; Lars Østergaard; Ole S Søgaard; Bruce D Wines; P Mark Hogarth; Arnold Reynaldi; Miles P Davenport; Sean Emery; Janaki Amin; David A Cooper; Virginia L Kan; Julie Fox; Henning Gruell; Matthew S Parsons; Stephen J Kent
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection.

Authors:  Leia H Wren; Amy W Chung; Gamze Isitman; Anthony D Kelleher; Matthew S Parsons; Janaki Amin; David A Cooper; Ivan Stratov; Marjon Navis; Stephen J Kent
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

6.  Short communication: antibody responses to human immunodeficiency virus envelope from infections with multiple subtypes utilize the 1F7-idiotypic repertoire.

Authors:  Matthew S Parsons; Robert J Center; Jean-Pierre Routy; Danielle Rouleau; Roger Leblanc; Mark A Wainberg; Cécile L Tremblay; Marcel D Zannou; Stephen J Kent; Michael D Grant; Nicole F Bernard
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01-29       Impact factor: 2.205

7.  Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.

Authors:  Vijaya Madhavi; Marjon Navis; Amy W Chung; Gamze Isitman; Leia H Wren; Robert De Rose; Stephen J Kent; Ivan Stratov
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

Review 8.  Role of Fc-mediated antibody function in protective immunity against HIV-1.

Authors:  George K Lewis
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 9.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

Review 10.  HIV vaccine development: an exploratory review of the trials and tribulations.

Authors:  David Rhys Alchin
Journal:  Immunol Res       Date:  2014-10       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.